DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Endroit courant :
> This Story

Forward Printable StoryPrint Comment




Cardiology Homepage

Philips receives FDA premarket approval for its HeartStart OnSite and HeartStart Home defibrillators

DIGISONICS receives ASE certification for the ImageGuideEcho Registry

RAPID by iSchemaView now available for use in Mexico

Guerbet announces group purchasing agreement with Premier to distribute novel microcatheters

Merit Medical acquires Brightwater Medical

Keynote speakers for the opening day of its annual scientific session this September in Chicago

Cardinal Analytx and Optima Health enter into multiyear strategic alliance to improve care and reduce costs

MR plays a role in diagnosis of cocaine-related damage to the heart

Higher coronary artery calcium levels in middle-age may indicate higher risk for future heart problems

Materialise receives FDA clearance for cardiovascular planning software suite

SIR publishes multisociety position statement on prostatic artery embolization

Press releases may be edited for formatting or style
FAIRFAX, VA (May 1, 2019)—Prostatic artery embolization (PAE) is a safe, effective, and minimally invasive treatment for enlarged prostate and should be presented as a treatment option for appropriately selected patients, the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, the Société Française de Radiologie and the British Society of Interventional Radiology said in a new position statement.

The multisociety and multidisciplinary position statement, which was published in the May edition of SIR’s Journal of Vascular and Interventional Radiology, recommends PAE as a “valuable minimally invasive option for patients who cannot tolerate or who have failed medical therapy, and those who are poor surgical candidates or refuse invasive surgery.”

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

Enlarged prostate, also known as benign prostatic hyperplasia (BPH), is one of the most common medical conditions in older men, affecting 70 percent of men over 70. More than 20 studies including over 2,000 patients with moderate to severe lower urinary tract symptoms (LUTS) due to BPH show that PAE has shorter recovery and fewer complications than traditional surgery and improves symptoms and quality of life to a greater degree than medical therapy.

The societies endorse PAE as “a definitive treatment option for multiple underserved patient groups, who may not have satisfactory urologic treatment options.” These patient groups include older patients with multiple medical conditions, patients with very large prostates, patients with bleeding from the prostate, patients with long-term bladder catheters, patients who cannot stop anti-coagulation therapies and patients who desire to preserve sexual function. “These patients are often poor candidates for surgery, but can be excellent candidates for PAE,” the societies said in the statement.

During PAE, an interventional radiologist makes a tiny puncture in either the groin or wrist to insert a catheter into an artery and, using image guidance, directs the catheter to the blood vessels on both sides of the enlarged prostate gland. The doctor uses small beads to block the blood flow to the prostate, which results in the gland’s shrinkage. Unlike surgery, PAE avoids access through the urethra, anesthesia, and hospitalization.

Read the position statement and full list of recommendations here. In addition to the four societies that authored the guidelines, the guidelines were endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology.

About the Society of Interventional Radiology
The Society of Interventional Radiology is a nonprofit, professional medical society representing more than 8,000 practicing interventional radiology physicians, trainees, students, scientists and clinical associates, dedicated to improving patient care through the limitless potential of image-guided therapies. SIR’s members work in a variety of settings and at different professional levels—from medical students and residents to university faculty and private practice physicians.

Cardiology Homepage

You Must Be Logged In To Post A Comment

La publicité d'email
Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Voir les utilisateurs récemment certifiés
Voir les utilisateurs récemment certifiés
Récemment évalué sur DOTmed
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service Technicians Forum
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2019, Inc.